The phenomenon of multidrug resistance caused by the over-expression of ABC transporter drug efflux pumps that have broad pump substrate specificities like P-glycoprotein has been particularly problematic due to the fact that these cellular defense proteins can limit the intracellular concentrations of drugs to sub-therapeutic levels specifically in the cancer cells [35, 36]. The gene discussed is PROS1; the disease is cancer.